Endpoints News 2026년 4월 6일 Amgen seeks to buoy Tepezza with injectable data in face of incoming competition
Endpoints News 2025년 12월 12일 FDA broadens label for Amgen's Uplizna as it enters rare disease competition
Endpoints News 2025년 12월 11일 Weight loss biotech Prolynx gets $70M, snags Amgen's obesity commercial leader as CEO